NCT01725776View on ClinicalTrials.gov

Inhaled Milrinone in Cardiac Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

February 29, 2012

Study Completion Date

June 30, 2012

Conditions
Pulmonary Hypertension
Interventions
DRUG

Inhaled milrinone 5 mg

Inhaled milrinone 5 mg (as for the injectable solution)

Trial Locations (1)

Unknown

Montreal Heart Institute, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Fonds de la Recherche en Santé du Québec

OTHER_GOV

collaborator

St. Justine's Hospital

OTHER

lead

Montreal Heart Institute

OTHER

NCT01725776 - Inhaled Milrinone in Cardiac Surgery | Biotech Hunter | Biotech Hunter